Medicare Enrolled
Dr. Brian Sorin, M.D.
Neurology · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sorin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sorin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sorin
Dr. Brian Sorin is a neurology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Sorin performed 53,107 Medicare services across 966 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sorin received a total of $48,331 from 76 pharmaceutical and/or device companies across 1219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sorin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $48,331 industry payments
Medicare Practice Summary
Medicare Utilization ↗53,107
Medicare services
Top 1% in TX for neurology
966
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,795 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 19,464 | $4 | $10 |
| Botox injection (Xeomin), per unit | 18,900 | $4 | $7 |
| Injection, abobotulinumtoxina, 5 units | 8,700 | $6 | $9 |
| Injection, propofol, 10 mg | 2,130 | $0 | $5 |
| Anti-nausea injection (ondansetron/Zofran) | 565 | $0 | $15 |
| Injection, ketorolac tromethamine, per 15 mg | 525 | $0 | $15 |
| Injection, magnesium sulfate, per 500 mg | 227 | $1 | $15 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 197 | $44 | $150 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 196 | $0 | $30 |
| Injection, acetaminophen, not otherwise specified,10 mg | 193 | $0 | $100 |
| Ultrasonic guidance for needle placement | 186 | $40 | $325 |
| Office visit, established patient (30-39 min) | 182 | $82 | $175 |
| Injection, methocarbamol, up to 10 ml | 166 | $4 | $100 |
| Injection, midazolam hydrochloride, per 1 mg | 145 | $0 | $30 |
| Injection, thiamine hcl, 100 mg | 142 | $2 | $50 |
| Injection of chemical for paralysis of nerve muscles on side of face | 140 | $135 | $420 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 137 | $74 | $420 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 134 | $1 | $16 |
| Office visit, established patient (20-29 min) | 85 | $61 | $125 |
| Injection of trigger points, 3 or more muscles | 81 | $25 | $150 |
| Injection of chemical for paralysis of nerve muscles on trunk, 6 or more muscles | 81 | $64 | $500 |
| Destruction of first division of face nerve branch | 76 | $200 | $1,000 |
| Unclassified drugs | 65 | $1 | $16 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 60 | $13 | $60 |
| Injection, lorazepam, 2 mg | 55 | $1 | $15 |
| Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | 53 | $56 | $500 |
| Injection, orphenadrine citrate, up to 60 mg | 49 | $4 | $30 |
| Application of electrical stimulation with therapist present, each 15 minutes | 48 | $8 | $50 |
| Injection, diphenhydramine hcl, up to 50 mg | 31 | $1 | $15 |
| Injection of anesthetic agent, trigeminal nerve bundle | 30 | $120 | $420 |
| Blood draw (venipuncture) | 22 | $8 | $25 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 21 | $37 | $300 |
| Drug injection, under skin or into muscle | 21 | $10 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
97.9% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,331
Total received (2018-2024)
Avg $6,904/year across 7 years
Top 10% in TX for neurology
76
Companies
1,219
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,404 (52.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,221 (43.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,706 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,014
2023$2,432
2022$3,053
2021$8,166
2020$9,441
2019$12,611
2018$9,614
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$13,053
Teva Pharmaceuticals USA, Inc.
$9,450
Amgen Inc.
$8,596
Lundbeck LLC
$1,713
ABBVIE INC.
$1,274
AbbVie Inc.
$1,085
Merz Pharmaceuticals, LLC
$1,065
Supernus Pharmaceuticals, Inc.
$784
Lilly USA, LLC
$759
US WorldMeds, LLC
$695
Novartis Pharmaceuticals Corporation
$632
Avanir Pharmaceuticals, Inc.
$543
PFIZER INC.
$537
REVANCE THERAPEUTICS, INC.
$509
Biohaven Pharmaceutical Holding Company Ltd.
$503
UCB, Inc.
$498
Merz North America, Inc.
$454
Biogen, Inc.
$453
Allergan, Inc.
$426
Biohaven Pharmaceuticals, Inc.
$402
Bausch Health US, LLC
$386
Allergan Inc.
$382
Celgene Corporation
$354
MERZ NORTH AMERICA, INC.
$301
Horizon Therapeutics plc
$274
Genentech USA, Inc.
$232
GENZYME CORPORATION
$179
Grifols USA, LLC
$166
Endo Pharmaceuticals Inc.
$156
Assertio Therapeutics, Inc.
$153
Promius Pharma LLC
$149
EMD Serono, Inc.
$135
Egalet US Inc
$122
ASSERTIO THERAPEUTICS, Inc.
$112
Alexion Pharmaceuticals, Inc.
$98
Otsuka America Pharmaceutical, Inc.
$93
Upsher-Smith Laboratories LLC
$91
Currax Pharmaceuticals LLC
$87
UPSHER-SMITH LABORATORIES LLC
$77
Takeda Pharmaceuticals U.S.A., Inc.
$76
Axsome Therapeutics, Inc.
$68
Sunovion Pharmaceuticals Inc.
$67
Inspire Medical Systems, Inc.
$67
SK Life Science, Inc.
$66
Vertiflex, Inc.
$59
Horizon Pharma plc
$58
NOVARTIS PHARMACEUTICALS CORPORATION
$57
TG Therapeutics, Inc.
$56
Abbott Laboratories
$55
Harmony Biosciences LLC
$50
GE Healthcare
$47
Zyla Life Sciences
$47
Vertical Pharmaceuticals, LLC
$46
OptiNose US, Inc.
$42
GE HEALTHCARE
$41
Acorda Therapeutics, Inc
$40
SCILEX PHARMACEUTICALS INC.
$39
ARGENX US, INC.
$32
Mallinckrodt Enterprises LLC
$31
Shire North American Group Inc
$27
LivaNova USA, Inc.
$26
Xeris Pharmaceuticals, Inc.
$26
Amneal Pharmaceuticals LLC
$25
GRT US Holding, Inc.
$24
Merck Sharp & Dohme LLC
$21
TG THERAPEUTICS, INC.
$19
Zyla Life Sciences, Inc.
$18
EISAI INC.
$18
Neurelis, Inc.
$17
Eisai Inc.
$15
Integra LifeSciences Corporation
$14
IMPEL PHARMACEUTICALS INC.
$13
Arbor Pharmaceuticals, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$12
Pernix Therapeutics Holdings, Inc.
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 64.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CODMAN CERTAS · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DAXXIFY · DUEXIS · DYSPORT · Dysport · EMGALITY · Enspryng · Fycompa · GAMMAGARD · GILENYA · GRALISE · Gamunex-C · Gralise · Horizant · INFINITY · INSPIRE · KESIMPTA · KEVEYIS · KRYSTEXXA · LEMTRADA · LORZONE · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · MIGRANAL · MYOBLOC · Mavenclad · NASCOBAL · NORTHERA · NUEDEXTA · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONZETRA · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Octrode SCS Leads · Ozanimod · PAXLOVID · PLEGRIDY · POMPE - DISEASE · Prodigy Family of SCS IPGs · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · Qutenza · RAYOS · RYTARY · SILENOR · SOLIRIS · SPRIX · Sunosi · Superion ISS · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XEOMIN · Xadago · Xeomin · Xhance · ZEPOSIA · ZIPSOR · ZOMIG · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (53%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for neurology in TX.
Equivalent to $91 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
231
Per 100K population
20.7
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sorin is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (consulting-driven, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sorin experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Sorin performed 19,464 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sorin receive payments from pharmaceutical companies?
Yes. Dr. Sorin received a total of $48,331 from 76 companies across 1,219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sorin's costs compare to other neurologys in Plano?
Dr. Sorin's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sorin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Plano
Browse neurologys in Plano ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology